Evidence map›Paper›PMID 24184417›Full record

ArticleNeuropharmacology2014

Synaptic plasticity in glutamatergic and GABAergic neurotransmission following chronic memantine treatment in an in vitro model of limbic epileptogenesis.

Shuijin He, Suzanne B Bausch

Abstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shuijin HeGraduate Program in Neuroscience, Uniformed Services University, School of Medicine, Bethesda, MD 20814, USA.
Suzanne B BauschDepartment of Pharmacology, Uniformed Services University, School of Medicine, Bethesda, MD 20814, USA; Graduate Program in Neuroscience, Uniformed Services University, School of Medicine, Bethesda, MD 20814, USA. Electronic address: suzanne.bausch@usuhs.edu.

Funding

Glutamate Receptors in EpileptogenesisR01NS045964 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BAUSCH, SUZANNE B · 2004 to 2007
$1.1M
NINDS NIH HHS NS045964NINDS NIH HHS R01 NS045964
6 · The paper itself

Abstract

Chronic N-methyl-D-aspartate receptor (NMDAR) blockade with high affinity competitive and uncompetitive antagonists can lead to seizure exacerbation, presumably due to an imbalance in glutamatergic and GABAergic transmission. Acute administration of the moderate affinity NMDAR antagonist memantine in vivo has been associated with pro- and anticonvulsive properties. Chronic treatment with memantine can exacerbate seizures. Therefore, we hypothesized that chronic memantine treatment would increase glutamatergic and decrease GABAergic transmission, similar to high affinity competitive and uncompetitive antagonists. To test this hypothesis, organotypic hippocampal slice culture were treated for 17-21 days with memantine and then subjected to electrophysiological recordings. Whole-cell recordings from dentate granule cells revealed that chronic memantine treatment slightly, but significantly increased sEPSC frequency, mEPSC amplitude and mEPSC charge transfer, consistent with minimally increased glutamatergic transmission. Chronic memantine treatment also increased both sIPSC and mIPSC frequency and amplitude, suggestive of increased GABAergic transmission. Results suggest that a simple imbalance between glutamatergic and GABAergic neurotransmission may not underlie memantine's ictogenic properties. That said, glutamatergic and GABAergic transmission were assayed independently of one another in the current study. More complex interactions between glutamatergic and GABAergic transmission may prevail under conditions of intact circuitry.

Indexed as

AnimalsExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidGlutamic AcidHippocampusMemantineNeuronal PlasticityNeuronsRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateSeizuresSynapsesSynaptic TransmissionExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidGlutamic AcidMemantineReceptors, N-Methyl-D-Aspartate6-cyano-7-nitroquinoxaline-2,3-dioneaCSFartificial cerebrospinal fluidbicuculline methiodideBMICNQXD(−)-2-amino-5-phosphonopentanoic acidD-APVDentate granule cellElectrophysiologyGABAHippocampuslarge amplitude spontaneous excitatory postsynaptic currentmEPSCminiature excitatory postsynaptic currentminiature inhibitory postsynaptic currentmIPSCNMDARN-methyl-d-aspartate receptorspostsynaptic currentPSCresting membrane potentialResting membrane potentialRMPSEMsEPSCsEPSC(large)sEPSC(small)sIPSCSlice culturesmall amplitude spontaneous excitatory postsynaptic currentspontaneous excitatory postsynaptic currentspontaneous inhibitory postsynaptic currentstandard error of the meantetrodotoxinTTXγ-aminobutyric acid

Identifiers

PMID24184417
PMCPMC3880158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.